Intellia Therapeutics (NTLA) Receivables - Other (2015 - 2023)
Intellia Therapeutics (NTLA) recorded Receivables - Other of $1 million in Q4 2023, down 73.0% from $3.7 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Receivables - Other (2015 - 2023) Analysis & Trends
Starting with Q4 2015, Intellia Therapeutics' Receivables - Other history includes 31 quarters.
- Annual Receivables - Other has a five-year compound annual growth rate of -30.1% (FY2018 to FY2023).
- Across earlier years, Receivables - Other came in at $3.7 million in FY2022, $100,000 in FY2021 (-95.2%), $2.1 million in FY2020 (-41.7%) and $3.6 million in FY2019 (-40.0%).
- Quarterly Receivables - Other has ranged from $100,000 in Q4 2021 to $8.4 million in Q1 2020 over the past five years.
- On a year-over-year basis, Receivables - Other has declined for three consecutive quarters, with growth averaging 22.9% over the last six quarters.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 740.0% in Q1 2020, against a decline of 95.2% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $1 million (Q3 2023), $1.4 million (Q2 2023) and $4.8 million (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Intellia Therapeutics | 1.57 Bn | -171.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 4.80 Mn |
| Dec 31, 2022 | 3.70 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 2.90 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 2.10 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 2.10 Mn |
| Sep 30, 2020 | 1.20 Mn |
| Jun 30, 2020 | 3.90 Mn |
| Mar 31, 2020 | 8.40 Mn |
| Dec 31, 2019 | 3.60 Mn |
| Sep 30, 2019 | 1.00 Mn |
| Jun 30, 2019 | 1.00 Mn |
| Mar 31, 2019 | 1.00 Mn |
| Dec 31, 2018 | 6.00 Mn |
API Access
Intellia Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();